Rana Suzette Bonds, MD

CURRICULUM VITAE

NAME: Rana S. Bonds, M.D.

PRESENT POSITION AND ADDRESS:

Assistant Professor, Interim Director
Division of Allergy and Immunology
Department of Internal Medicine
University of Texas Medical Branch

EDUCATION:

08/1989 to 05/1992: Peabody Magnet High School
Valedictorian
Alexandria, LA

09/1992 to 06/1993: Centenary College
Shreveport, LA

09/1993 to 06/1996: B.S. Loyola University of New Orleans
Magna cum laude
New Orleans, LA

07/1996 to 06/2002: M.D. Baylor College of Medicine
Houston, TX

07/2002 to 06/2005: Resident Internal Medicine
Ochsner Clinic Foundation
New Orleans, LA

07/2005 to 06/2007: Fellow Allergy/Immunology
University of Texas Medical Branch
Galveston, TX

BOARD CERTIFICATION:

American Board of Internal Medicine
Certification, 2005

American Board of Allergy and Immunology
Certification, 2007

PROFESSIONAL AND TEACHING EXPERIENCE:

2010-present: Interim Director, Division of Allergy & Immunology, University of Texas Medical Branch

2009-present: Medical Director, University of Texas Medical Branch Clearlake Specialty Clinic

2009-present: Director of Allergy Services, University of Texas Medical Branch

2008-present: Associate Training Program Director Allergy/Immunology Fellowship Training Program, University of Texas Medical Branch. My responsibilities include curriculum development, coordinating lecture series and board review, ensuring fellowship compliance with ACGME requirements, arranging elective rotations, and general mentoring of 7 fellows.

2007-present: Assistant Professor, Department of Internal Medicine, University of Texas Medical Branch

2001: Faculty Advisor, National Youth Leadership Forum (Houston-Galveston)
My responsibilities included supervising a group of 23 high school students daily during informational tours, community leaders’ presentations, and social outings. I also facilitated small group discussions regarding health delivery issues, taught the technique of problem based learning, and facilitated medical ethics debates and the development of a public health project.

RESEARCH ACTIVITIES:

2009 - present: Baxter (160603): Efficacy, Tolerability and Pharmacokinetic Comparison of Immune Globulin Intravenous (Human), 10% (Gammagard Liquid/KIOVIG) Administered Intravenously or Subcutaneously Following Administration of Recombinant Human Hyaluronidase (rHuPH20) in Subjects with Primary Immunodeficiency Diseases, University of Texas Medical Branch

2009 - present: Shire (HGT-FIR-054): A Phase III Randomized Double-Blind, Placebo-controlled Multicenter Study of Icatibant for Subcutaneous Injection in Patients with Acute Attacks of Hereditary Angioedema (HAE), University of Texas Medical Branch

2007 - present: Human Response to Inhaled and Ingested Allergens—Perimenstrual Asthma, University of Texas Medical Branch

2005 - present: Oral Allergy Syndrome Due to Cross Reactivity of Mountain Cedar and Tomato Allergens, University of Texas Medical Branch, Galveston, TX

2009 - present: Back Up Independent Safety Monitor, NIH NIAID DMID Protocol 09-0058, University of Texas Medical Branch
My responsibilities include reviewing safety data collected per study protocol, discussing and/or presenting findings at regularly scheduled meetings, and monitoring for indicators of hazards to the safety of study subjects.

2009: Back Up Independent Safety Monitor, NIH NIAID DMID Protocol 08-0013 H1N1 vaccine study, University of Texas Medical Branch
My responsibilities include reviewing safety data collected per study protocol, discussing and/or presenting findings at regularly scheduled meetings, and monitoring for indicators of hazards to the safety of study subjects.

2007: Back Up Data and Safety Monitor, VaxInnate 102, University of Texas Medical Branch
My responsibilities included reviewing safety data collected per study protocol, presenting findings at regularly scheduled meetings, and monitoring for indicators of hazards to the safety of study subjects.

2005 - 2009: LevPharma Purified C1 inhibitor in hereditary angioedema(LEVP2005-1): Randomized, double blind, placebo controlled clinical study to investigate safety and efficacy of purified C1 inhibitor in the treatment of acute attacks of HAE and as prophylaxis for attacks; University of Texas Medical Branch, Galveston, TX

2004 - 2005: Cross Reactivity of Legume Allergens (Soheila Maleki, Ph.D.), Southern Regional Research Center U.S. Department of Agriculture, New Orleans, LA.

1995 - 1996: Vanadium Compounds as Catalysts for Organic Reactions: (Kurt Birdwhistle, Ph.D.), Loyola University New Orleans, LA (for the U. S. Department of Energy)

MEMBERSHIP IN SCIENTIFIC SOCIETIES:

American Academy of Allergy, Asthma, and Immunology
American College of Allergy, Asthma and Immunology
Texas Allergy, Asthma, and Immunology Society
Greater Houston Allergy Society

HONORS:

• AAMC Early Career Women Faculty Professional Development Seminar (competitive admission), 2010
• Outstanding Resident of the Year, Ochsner Clinic Foundation, 2005
• Highest Score in Class, Internal Medicine In-Service Exam, Ochsner Clinic Foundation, 2002

A. ARTICLES IN PEER-REVIEWED JOURNALS:

1. Bonds RS, Midoro-Horiuti T, Goldblum R. Structural basis for food allergy: a role for cross-reactivity. Curr Opin Allergy Clin Immunol 2008;8(1):82-6.
2. Bonds RS, Grant JA, Calhoun WJ. Allergic disorders: When should you                consider immunotherapy? Consultant 2007; 47: 405.

B. BOOK CHAPTERS

1. Bonds RS, Rais M, Castillo J, Grant JA.  Immunotherapy for Allergic Rhinitis. In: Current Review of Rhinitis, 2nd edition. Ed. Kaliner MA. Current Medicine LLC 2006.

C. OTHER:
1. Ochsner Clinic Foundation Treatment Protocol for Allergic Rhinitis: RS Bonds, MD and B Winthrop, MD, MPH. Ochsner Clinic Foundation Physician Best Practices. 
 
D. ABSTRACTS:
 
1. Bonds RS, Tiwari R, Ning Bo, Czerwinski E, Goldblum R, Midoro-Horiuti T. Cross reactivity in mountain cedar-tomato oral allergy syndrome. J All Clin Immunol 2007; 119: S113. (Also presented at scientific poster session of the American Academy of Allergy, Asthma, and Immunology National Meeting 2007) 
2. Bonds RS, Grant JA.  Rapid desensitization in a patient with insulin allergy.  Ann All Asthma Immunol 2007; 98:A113. (Also presented at scientific poster session of the American College of Allergy, Asthma, and Immunology National Meeting 2007) 
3. Redding D, Grant JA, Bonds RS. The development of cutaneous mastocytosis in association with wasp sting anaphylaxis. Ann All Asthma Immunol 2007; 98:A51.
4. Bonds RS, McBride J, Cheng H, Maleki SJ. In vitro cross-reactivity of peanut allergens with other legumes. J All Clin Immunol 2006; 117:S39. (Also presented at scientific poster session of the American Academy of Allergy, Asthma, and Immunology National Meeting 2006) 
5. Bonds RS, Bain M, Grant JA. Hereditary angioedema involving seven generations. Ann All Asthma Immunol 2006; 96:138. (Also presented at oral scientific session of the American College of Allergy, Asthma, and Immunology National Meeting 2005)